- Length
- Date
- Resolution
- Source
- Price
- Clear filters
- SafeSearch:
- Moderate
See more
More like this
Nuvalent Inc. | Nuvalent Clinical Trials
Sponsored Read Nuvalent's research in a brain-penetrant ROS1-selective inhibitor for ROS1+ NSCL…Precision-Based Pipeline · Targeted Research · Multi-Asset Pipeline · ROS1 & ALK Selectivity
